Optimizing Medical Decision-Making for Older Patients with Type 2 DiabetesMedicare-age patients with type 2 diabetes are projected to double in the next 25 years and have high rates of complications and adverse drug events. However, older patients are largely excluded from the major clinical trials of diabetes care. This lack of clinical evidence has led to conflicting and ambiguous recommendations for care. The study will provide new evidence needed to care for these patients. Aim 1: Characterize variation in patient-reported outcomes, patient-provider relationships, and treatment preferences. Aim 2: Determine glycemic control levels associated with the lowest risk of adverse outcomes, including micro- and macrovascular outcomes, hypoglycemia, and death. Aim 3: Develop a risk-based decision support tool for evidence-based, individualized diabetes care for older adults with diabetes.
Investigator: Karter, Andrew
Funder: National Institute on Aging